Healthcare systems post-COVID: pressing reset? 29-10-2020


ESIP participates in a POLITICO panel on how to increase healthcare systems' sustainability

On October 28, Ilka Woelfle - ESIP's President - represented ESIP in a POLITICO panel discussion on Healthcare systems post-COVID 19: pressing reset? bringing to the table payers’ views on how to increase the sustainability of healthcare systems. The panel was also joined by representatives of healthcare professionals, patients as well as by Andrzej Rys, from the European Commission Directorate General for Health and Food Safety (DG SANTE).

Crucial role of social security to fight child poverty 07-10-2020


ESIP gives its feedback to the European Child Guarantee roadmap

The Family and Social Inclusion Committee (FaSI) of ESIP, gathering institutions responsible for the provision of family and child benefits, as well as services to children, including early childhood education and care (ECEC), took the opportunity provided by the Commission's roadmap on the European Child Guarantee to offer in expertise. 

Tackling Medicine Shortages beyond COVID-19 28-09-2020


Actions to secure continuous supply of quality, effective and safe medicines

The ongoing COVID-19 pandemic highlighted existing shortcomings in healthcare systems across the EU: supply chains of both medicinal products and medical devices have been impacted by the crisis, increasing the risks of shortages of essential drugs and equipment and consequently causing treatment delays and disruptions. Hence, the temporary and permanent unavailability of medicines severely affects patients’ health and puts a serious strain on European healthcare systems.

Transparency in the EU's Vaccines Strategy 18-09-2020


ESIP joins the Fair Pricing Coalition calling for transparent investment on COVID-19 vaccines

The COVID-19 crisis has put strains on healthcare system in Europe and across the world. In the attempt to overcome the crisis, the EU engaged in a number of measures and initiatives aimed at countering disruptions in the European health, economic and social systems. Amongst others, the COVID-19 European vaccine strategy, based on Advance Purchase Agreements (APAs), has been used for the join procurement of vaccines for COVID-19.